Ignacio D.
- Country
- Spain
- Department
- Oncología
Research Overview
- Phase 2 Randomized Trial of Neoadjuvant Pembrolizumab and Belzutifan with or without Lenvatinib in Patients with Localized Renal Cell Carcinoma
- A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versus Placebo in Subjects with High Risk Invasive Urothelial Carcinoma
- Evaluation of Talazoparib and Enzalutamide Efficacy in Metastatic Castration-Resistant Prostate Cancer Post-Abiraterone Progression
Data & Insights
Has run more than one trial at 86 of 229 partner sites.
Specializations
Solid Tumor Oncology
Focuses on malignant neoplasms of diverse organ systems, emphasizing targeted and immunotherapeutic strategies.
- Advanced Non‑Small Cell Lung Cancer
- Metastatic Colorectal Cancer
- Hepatocellular Carcinoma
- Renal Cell Carcinoma
- Triple‑Negative Breast Cancer
Engagement includes both early‑stage and refractory disease settings.
Hematologic Malignancies
Addresses malignant disorders of the blood and bone marrow, with emphasis on novel cellular and antibody‑based therapies.
- Acute Myeloid Leukemia
- Diffuse Large B‑Cell Lymphoma
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
Research spans frontline treatment and relapsed/refractory disease.
Metabolic Liver Disease
Concentrates on progressive fatty liver disorders linked to metabolic dysfunction.
- Non‑Alcoholic Steatohepatitis
- Metabolic Dysfunction‑Associated Steatohepatitis
- Cirrhosis
- Hepatocellular Carcinoma arising from NASH
- Liver Fibrosis
Investigations target disease modification and fibrosis regression.
Autoimmune & Inflammatory Disorders
Explores systemic immune‑mediated conditions, prioritizing disease‑modifying agents.
- Systemic Lupus Erythematosus
- Psoriatic Arthritis
- Idiopathic Inflammatory Myopathies
- Rheumatoid Arthritis
- Primary Biliary Cholangitis
Includes both organ‑specific and systemic manifestations.
Cardiovascular & Thrombotic Disease
Targets atherosclerotic and thrombotic pathologies, with a view to reducing major adverse cardiovascular events.
- Atherosclerotic Cardiovascular Disease
- Acute Myocardial Infarction
- Elevated Lipoprotein(a)
- Venous Thromboembolism
- Peripheral Artery Disease
Emphasis on lipid modulation and anti‑inflammatory strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.